These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5703966)

  • 1. Low-molecular dextran in chronic circulatory failure. Effect estimated by lung diffusing capacity.
    Solvsteen P; Nathan E
    Acta Med Scand; 1968; 184(1-2):79-82. PubMed ID: 5703966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

  • 3. The arteriographic appearances following the use of intra-arterial vasodilator agents in occlusive arterial disease.
    Ainsworth J; Rose SS
    Clin Radiol; 1967 Oct; 18(4):439-44. PubMed ID: 6073915
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of iron (113mIn) hydroxide particles on pulmonary diffusing capacity and pulmonary artery pressure.
    Brashear RE; Mishkin FS; Ross JC
    Invest Radiol; 1969; 4(1):19-23. PubMed ID: 5766173
    [No Abstract]   [Full Text] [Related]  

  • 5. [PROLONGED INTRA-ARTERIAL INFUSIONS WITH VASODILATORS AND LOW-MOLECULAR WEIGHT DEXTRAN IN THE TREATMENT OF PERIPHERAL ARTERIAL CIRCULATION DISORDERS].
    MARTI WK
    Schweiz Med Wochenschr; 1963 Dec; 93():1746-9. PubMed ID: 14098621
    [No Abstract]   [Full Text] [Related]  

  • 6. [The valve of intra-arterial perfusion of low molecular weight dextran, vasodilating drugs and heparin in arterial disease of the lower extremities].
    Mercier C; Juhan C
    Ann Chir; 1968 May; 22(9):661-6. PubMed ID: 5684563
    [No Abstract]   [Full Text] [Related]  

  • 7. The distribution of ventilation, perfusion, lung volume and transfer factor (diffusing capacity) in patients with obstructive lung disease.
    King TK; Briscoe WA
    Clin Sci; 1968 Aug; 35(1):153-70. PubMed ID: 5679884
    [No Abstract]   [Full Text] [Related]  

  • 8. Microscopic studies of the pulmonary circulation in situ.
    Webb WR; Wax SD; Kusajima K; Kamiyama TM
    Surg Clin North Am; 1974 Oct; 54(5):1067-76. PubMed ID: 4608865
    [No Abstract]   [Full Text] [Related]  

  • 9. [Further observations on the relationships between pulmonary diffusion and circulatory and respiratory volume].
    Dagianti A; Verde AM; Giordano G; Angrisani P; Mastroberardino G; Fiori G
    Clin Ter; 1967 Jul; 42(2):113-9. PubMed ID: 5596411
    [No Abstract]   [Full Text] [Related]  

  • 10. Decrease in pulmonary diffusing capacity during exercise in chronic obstructive lung diease.
    Suero JT; Woolf CR
    Am Rev Respir Dis; 1970 Apr; 101(4):608-10. PubMed ID: 5439881
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic responses to whole blood and blood substitutes in clinical shock.
    Carey JS; Woodward NW; Brown R; Mohr P; Seward P; Shoemaker WC
    Surg Forum; 1965; 16():31-3. PubMed ID: 5835174
    [No Abstract]   [Full Text] [Related]  

  • 12. Low molecular weight dextran and matching by enzyme technics.
    Murray S; Dewar PJ
    Transfusion; 1971; 11(6):378-81. PubMed ID: 5136070
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of isoproterenol on gas exchange during air and oxygen breathing in patients with chronic pulmonary diseases.
    Gazioglu K; Kaltreider NL; Hyde RW
    Am Rev Respir Dis; 1971 Aug; 104(2):188-97. PubMed ID: 5558987
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of arteriosclerotic circulatory disorders].
    Nobbe F
    Z Allgemeinmed; 1974 Jul; 50(21):957-64. PubMed ID: 4152664
    [No Abstract]   [Full Text] [Related]  

  • 15. Three-dimensional, unsteady simulation of alveolar respiration.
    Kulish VV; Lage JL; Hsia CC; Johnson RL
    J Biomech Eng; 2002 Oct; 124(5):609-16. PubMed ID: 12405604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusing capacity of the lung in Caucasians native to 3,100 m.
    DeGraff AC; Grover RF; Johnson RL; Hammond JW; Miller JM
    J Appl Physiol; 1970 Jul; 29(1):71-6. PubMed ID: 5425040
    [No Abstract]   [Full Text] [Related]  

  • 17. Decrease of diffusing capacity and pulmonary blood flow during passive lung inflation.
    Fisher AB; Hyde RW
    J Appl Physiol; 1969 Aug; 27(2):157-63. PubMed ID: 5796302
    [No Abstract]   [Full Text] [Related]  

  • 18. [The distribution analysis of ventilation, perfusion, and O2 diffusing capacity in the lung, through concentration changes for 3 inspiratory gases. 3. Tests on adolescents, elderly people, and pregnant women].
    Vogel HR; Thews G; Schulz V; von Mengden HJ
    Pflugers Arch; 1968; 303(3):218-29. PubMed ID: 5693723
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comments on the problem of plasma substitutes in military medicine and emergencies].
    Allgöwer M
    Helv Chir Acta; 1967 Dec; 34(6):551-65. PubMed ID: 5587954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma substitutes of the dextran series in therapy of some dermatoses].
    Braga VM; Kuz'mina NF; Onoprienko SN; Tsyganok SS
    Vestn Dermatol Venerol; 1977 Apr; (4):75-8. PubMed ID: 899222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.